TechNavio recognizes the following companies as the key players in the Global Protein Therapeutics Market: Roche Holding, Amgen, Abbott Laboratories, J and J, and Novo Nordisk.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: “The development and manufacture of drugs is a complex and time-consuming process, and also requires huge financial investments. As many vendors in the market are facing the problem of declining venture capital investments, they are increasingly following the strategy of outsourcing. Many vendors outsource different parts of the R&D process such as product characterization testing and toxicology testing to CROs. Likewise, a few vendors are increasingly outsourcing a part of their manufacturing process, or the entire manufacturing process to various organizations. Thus, the Global Protein Therapeutics market is currently witnessing the trend of increased outsourcing of drug development activities.”
According to the report, the growth of the Global Protein Therapeutics market is driven by several factors, the most important of which is the increase in the prevalence of chronic diseases such as cardiovascular diseases, neuro-degenerative diseases, cancer, diabetes, tuberculosis, HIV, and hepatitis. Protein therapeutic drugs are more effective in the treatment of these diseases than other pharmaceutical drugs and chemotherapies. Hence, the worldwide increase in the prevalence of chronic diseases is expected to foster the demand for protein therapeutic drugs, therefore contributing to the growth of the Global Protein Therapeutics market.
Further, the report states that one of the key challenges in the market is the patent expiration of top-selling drugs. Patent expiration results in the entry of a number of generic drugs in the market; therefore, leading to the decline in the prices of top-selling drugs. Thus, the patent expiry of drugs affects the growth of the market by resulting in reduced revenue generation.
The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are AstraZeneca plc, Biogen Idec Inc., Bristol Myers Squibb Co., Curis Inc., Eli Lilly and Co., Merck and Co. Inc., and Pfizer Inc.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/global-protein-therapeutics-market-2012…
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report – Global Protein Therapeutics Market 2012-2016
